CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Serum FGF21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia
DOI 10.1055/s-0029-1221912
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Ebert, S Stein, H Stepan, J Kratzsch, M Verlohren, HJ Verlohren, K Drynda, U Lössner, M Blüher, M Stumvoll, M Fasshauer
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Fibroblast growth factor 21 (FGF21) was recently introduced as a novel adipokine with beneficial effects on glucose homeostasis and insulin sensitivity. In contrast to other adipokines including adiponectin and leptin, concentrations of circulating FGF21 have not been evaluated so far in gestational diabetes mellitus (GDM). In the current study, we investigated serum concentrations of FGF21 in patients w…
Zitieren
Zitierempfehlung
T Ebert, S Stein, H Stepan, J Kratzsch, M Verlohren, HJ Verlohren, K Drynda, U Lössner, M Blüher, M Stumvoll, M Fasshauer (2009) Serum FGF21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0029-1221912
Mit CareLit weiterarbeiten